Sodium-glucose transporter 2 inhibitor for obstructive sleep apnea in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
{{output}}
Although sodium-glucose transporter 2 inhibitors (SGLT2is) are recommended medications for the treatment of type 2 diabetes mellitus (T2DM), conclusive evidence suggesting that they could alleviate the common complication of obstructive sleep apnea (OSA) in T2... ...
